Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$4.16 USD
+0.06 (1.34%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $4.15 -0.01 (-0.12%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
RMTI 4.16 +0.06(1.34%)
Will RMTI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RMTI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RMTI
Rockwell Medical (RMTI) is a Great Momentum Stock: Should You Buy?
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
RMTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue?
Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
Other News for RMTI
Rockwell Medical Announces Product Purchase Agreement with Leading At-Home and Acute Care Dialysis Provider
Rockwell Medical enters into product purchase agreement
Rockwell Medical Inc (RMTI) Stock Price Up 18.46% on Sep 9
Buy Rating Justified by Rockwell Medical’s Growth Prospects and Strategic Partnerships
Rockwell Medical Enters into Multi-Million Dollar Distribution Agreement with Nipro Medical Corporation